IncFact
Company Profiles: Revenue, Growth, Competition

PRELUDE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 
VC / Private Equity
Venture Capital / Private Equity

Company Profile & Annual Report for Prelude

Access the complete profile.

Prelude Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes62151
Address26051 Merit Circle
#102
Laguna Hills, CA 92653

Note: Revenues for privately held companies are statistical evaluations.


Prelude's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.


Prelude's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Prelude Annual Revenue and Growth Rate

Prelude Revenue Est.
($ Million)
Growth Rate (%)# Employees
2016 Details in Premium Report
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Prelude's revenues are gauged from an analysis of company filings.



Investor Activity

Prelude has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
July 27, 2018 7 100%$9 MM
Complete list of funding rounds and total amounts in the Company Report




Prelude's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Prelude Revenue (Sales) Prelude Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Prelude is developing and marketing. Prelude's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
DCISIONRT
Medical, prognostic and predictive services being medical diagnosis and treatment in the field of oncology; medical testing services for diagnostic or treatment purposes, including molecular and genetic testing; and pathology services for diagnostic or treatment purposes in the field of oncology
08/03/2017

See all trademarks and details in the Full Report.


Patent Applications

Patent applications show Prelude's intellectual property, its current capabilities and future direction. Prelude has applied for 1 patents since 2009. Prelude's most recent patent was filed in January 2012 for Cancer Biomarkers And Methods Of Use Thereof. Embodiments are provided for characterizing a biological sample. In some embodiments, one can estimate the risk that a subject with ductal carcinoma in situ will have a subsequent DCIS event and/or invasive cancers.


Patent Application Date
Complete list of patent applications




Recession Risk

Determine whether Prelude grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Prelude is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Competition: Prelude vs. Largest Competitors

A competitive analysis shows these companies are in the same general field as Prelude, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
SYNEOS HEALTHRaleigh, NC100 
ALEXION PHARMACEUTICALSNew Haven, CT88 
LEIDOS HOLDINGSReston, VA79 
CEPHALONFrazer, PA70 
VERTEX PHARMACEUTICALSBoston, MA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM59 




Nearby Competitors

These companies are similar in business line and location to Prelude. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
AVANIR PHARMACEUTICALSAliso Viejo, CA100 
PROOVE BIOSCIENCESIrvine, CA42 
MIND RESEARCH INSTITUTEIrvine, CA28 
BIT GROUP USAIrvine, CA17 
TYVAK NANO-SATELLITE SYSTEMSIrvine, CA13 
ERI ECONOMIC RESEARCH INSTITUTEIrvine, CA10 




Similar Sized Companies near Laguna Hills

These are similar in size and location to Prelude.

Company HeadquartersRevenue ($ MM)
J.S. DYER & ASSOCIATESIrvine, CA100 
AMERICAN RAIL ENGINEERSSan Juan Capistrano, CA100 
PQMHuntington Beach, CA100 
REGATTA SOLUTIONSSan Juan Capistrano, CA100 
IN S.T.E.P.P.S.Irvine, CA100 
NEW VISTA SCHOOLLaguna Hills, CA100 
BEHAVIORAL CONCEPTSLaguna Hills, CA100 
TRIPEPI SMITH & ASSOCIATES IIrvine, CA100 
GSR TECHNOLOGIESIrvine, CA100 
INTELLIGENT MEDICAL SOLUTIONS INLake Forest, CA100 
CHRISTOPHER A. ZACHARY D.D.S.Laguna Niguel, CA100 
J. K. MIKLINHuntington Beach, CA100 




Fastest Growing Competitors

These companies are in the same general field as Prelude and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Prelude Competitors